Guangxi Wuzhou Zhongheng Competitors and Similar CompaniesClear all

Guangxi Wuzhou Zhongheng's competitors and similar companies include Precise Group, Synergy Innovation, Abbott India and Lichtenheldt.

	Guangxi Wuzhou Zhongheng Guangxi Wuzhou Zhongheng (广西中恒集团) is a company that manufactures pharmaceuticals and food production.	Precise Group Precise is a company that manufactures drugs.	Synergy Innovation Synergy Innovation is a drug development company.	Abbott India Abbott India is a pharmaceutical company that offers medicinal drugs.	Lichtenheldt Lichtenheldt is a company that manufactures medicines, cosmetics, disinfectants, and dietary supplements.
Founding Date	Founding Date 1993	Founding Date 1997	Founding Date 1999	Founding Date 1944	Founding Date 1745
Type	Type Public	Type Private	Type Public	Type Public	Type Private
Tags	Tags Manufacturing & Industrial consumer products & services drug development medical devices pharma	Tags Manufacturing & Industrial drug development medical devices pharma	Tags Manufacturing & Industrial drug development medical devices pharma	Tags Manufacturing & Industrial drug development medical devices pharma pharmacy	Tags Healthcare cosmetics drug development pharma
Locations	Locations Wuzhou, CN HQ	Locations Mumbai, IN HQ Dindori, IN Jhalawar, IN Mumbai, IN Navi Mumbai, IN Navi Mumbai, IN	Locations Seongnam, KR HQ	Locations Mumbai, IN HQ Mumbai, IN Verna, IN	Locations Wahlstedt, DE HQ Wahlstedt, DE
Employees	Employees 2,971	Employees 5	Employees N/A	Employees 3,814	Employees 462% increase
Financial
Revenue (est.)	Revenue (est.) ¥1.7b (FY, 2025)	Revenue (est.) N/A	Revenue (est.) ₩113.1b (FY, 2025)	Revenue (est.) ₹69.3b (FY, 2026)	Revenue (est.) N/A
Cost of goods	Cost of goods ¥977.5m (FY, 2025)	Cost of goods N/A	Cost of goods ₩60.3b (FY, 2025)	Cost of goods ₹36.9b (FY, 2026)	Cost of goods N/A
Gross profit	Gross profit ¥733.1m (FY, 2025)	Gross profit N/A	Gross profit ₩53.4b (FY, 2025)	Gross profit ₹35.2b (FY, 2026)	Gross profit €23m (FY, 2020)
Net income	Net income (¥495.3m) (FY, 2025)	Net income N/A	Net income ₩11.2b (FY, 2025)	Net income ₹15.5b (FY, 2026)	Net income €3.1m (FY, 2020)